Xylazine toxicity: Difference between revisions
ClaireLewis (talk | contribs) |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Analogue of [[clonidine]] and agonist at [[alpha-2 agonists|alpha 2 adrenergic receptor]] | *Also known as "Tranq" | ||
*Analogue of [[clonidine]] and agonist at [[alpha-2 agonists|alpha 2 adrenergic receptor]]<ref>https://www.ncbi.nlm.nih.gov/pubmed/24769343</ref> | |||
*Veterinary sedative, anesthetic, analgesic, and muscle relaxant | *Veterinary sedative, anesthetic, analgesic, and muscle relaxant | ||
*Human drug of abuse, usually as drug adulterant | *Human drug of abuse, usually as drug adulterant without the knowledge of people who use these drugs | ||
**<u>Not</u> an opioid, but often combined with opioids and increases the risk of overdose and death | |||
**Associated with complex skin infections when injected | |||
==Clinical Features== | ==Clinical Features== | ||
| Line 16: | Line 19: | ||
*Evaluate for alternate etiologies | *Evaluate for alternate etiologies | ||
*Clinical diagnosis | *Clinical diagnosis | ||
*Consider collecting serum toxicology tests specifically for xylazine, if available (for public health reasons; does not affect acute management) | |||
==Management== | ==Management== | ||
*Supportive: address airway/respiratory drive/blood pressure, [[atropine]] for bradycardia | *Supportive: address airway/respiratory drive/blood pressure, [[atropine]] for bradycardia | ||
*Consider administration of [[naloxone]] due to high likelihood that opioids are also present (does not directly affect xylazine toxicity) | |||
==Disposition== | ==Disposition== | ||
| Line 30: | Line 35: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Toxicology]] | [[Category:Toxicology]] | ||
Revision as of 15:41, 15 March 2023
Background
- Also known as "Tranq"
- Analogue of clonidine and agonist at alpha 2 adrenergic receptor[1]
- Veterinary sedative, anesthetic, analgesic, and muscle relaxant
- Human drug of abuse, usually as drug adulterant without the knowledge of people who use these drugs
- Not an opioid, but often combined with opioids and increases the risk of overdose and death
- Associated with complex skin infections when injected
Clinical Features
- Bradycardia
- Respiratory depression
- Hypotension
Differential Diagnosis
- See Bradycardia, Hypotension
Sedative/hypnotic toxicity
- Absinthe
- Barbiturates
- Benzodiazepines
- Chloral hydrate
- Gamma hydroxybutyrate (GHB)
- Baclofen toxicity
- Opioids
- Toxic alcohols
- Xylazine toxicity
Evaluation
- Evaluate for alternate etiologies
- Clinical diagnosis
- Consider collecting serum toxicology tests specifically for xylazine, if available (for public health reasons; does not affect acute management)
Management
- Supportive: address airway/respiratory drive/blood pressure, atropine for bradycardia
- Consider administration of naloxone due to high likelihood that opioids are also present (does not directly affect xylazine toxicity)
Disposition
- Admit if not back to baseline